{ "database": "PubMed (NCBI E-utilities esearch/efetch)", "retrieved": "2026-10-17 (ET)", "note": "Jabbit searches for /research/cjc-1295-ipamorelin-growth-hormone-teardown.html. Counts are as returned on the retrieval date.", "searches": [ { "key": "cjc_all", "query": "\"CJC-1295\"[tiab] OR \"CJC 1295\"[tiab] OR CJC1295[tiab] OR \"DAC:GRF\"[tiab] OR \"DAC-GRF\"[tiab]", "count": 35, "note": "3 records report giving CJC-1295 (all with DAC) to people: PMIDs 16352683, 17018654, 19386527. Most others are doping-control detection methods or reviews.", "pmids": [ "42876013", "42862021", "42578445", "42395176", "42160466", "42123471", "42021992", "41966639", "41880199", "41490200", "41476424", "41138283", "38197510", "37806509", "38716080", "35298973", "34736642", "34665524", "32971474", "30938069", "30489688", "27710891", "26879649", "26771670", "26382721", "25382550", "23318763", "21871962", "21204297", "19386527", "19332789", "17018654", "16822960", "16352683", "15817669" ] }, { "key": "cjc_trial", "query": "(\"CJC-1295\"[tiab] OR \"CJC 1295\"[tiab] OR CJC1295[tiab] OR \"DAC:GRF\"[tiab]) AND (clinical trial[pt] OR randomized controlled trial[pt])", "count": 2, "note": "Teichman 2006 and Ionescu & Frohman 2006, both healthy volunteers, both CJC-1295 with DAC.", "pmids": [ "17018654", "16352683" ] }, { "key": "modgrf", "query": "\"modified GRF\"[tiab] OR \"Mod GRF\"[tiab] OR \"tetrasubstituted GRF\"[tiab] OR \"tetra-substituted GRF\"[tiab] OR \"GRF(1-29) tetrasubstituted\"[tiab]", "count": 5, "note": "No study of \"modified GRF (1-29)\" / CJC-1295 without DAC in people. The only on-topic hit (PMID 30136411) analyzes seized doping material; the rest are unrelated text matches.", "pmids": [ "38996639", "30136411", "29851844", "27722075", "27537844" ] }, { "key": "ipa_all", "query": "ipamorelin[tiab] OR \"NNC 26-0161\"[tiab]", "count": 51, "note": "Human dosing studies: Gobburu 1999 (healthy men, IV) and Beck 2014 (bowel surgery, IV). No subcutaneous human study.", "pmids": [ "42862021", "42578445", "42395176", "42160466", "42123471", "42021992", "41966639", "41880199", "41490200", "41476424", "39043357", "38996787", "32801950", "32257855", "30282322", "30168238", "30136411", "29864719", "27497113", "26811125", "26578461", "26472487", "25869809", "25331030", "24574167", "23318763", "23101768", "22901302", "27186127", "21298258", "19289567", "19231263", "16648303", "15665799", "15556068", "14630569", "12204475", "12168778", "11735244", "11459660", "11322495", "11162489", "10828840", "10629165", "10496658", "10427162", "10373343", "9879640", "9849822", "9733496", "9733495" ] }, { "key": "ipa_trial", "query": "(ipamorelin[tiab]) AND (clinical trial[pt] OR randomized controlled trial[pt])", "count": 2, "note": "Both intravenous.", "pmids": [ "25331030", "10496658" ] }, { "key": "ipa_human", "query": "ipamorelin[tiab] AND humans[mh]", "count": 25, "note": "MeSH \"Humans\" tag; mostly reviews and doping-detection papers.", "pmids": [ "42862021", "42395176", "42160466", "42123471", "41966639", "41880199", "41490200", "41476424", "30282322", "30168238", "29864719", "27497113", "26811125", "26578461", "26472487", "25869809", "25331030", "24574167", "23101768", "22901302", "21298258", "15556068", "14630569", "10496658", "10427162" ] }, { "key": "combo", "query": "(ipamorelin[tiab]) AND (\"CJC-1295\"[tiab] OR CJC1295[tiab] OR \"CJC 1295\"[tiab] OR \"GRF\"[tiab] OR GHRH[tiab] OR \"modified GRF\"[tiab])", "count": 16, "note": "None is a trial of ipamorelin combined with CJC-1295 or any GHRH analog in people: 10 are 2026 reviews, the rest rat studies or doping-control methods.", "pmids": [ "42862021", "42578445", "42395176", "42160466", "42123471", "42021992", "41966639", "41880199", "41490200", "41476424", "30136411", "23318763", "12168778", "10629165", "10373343", "9849822" ] }, { "key": "tesa_all", "query": "tesamorelin[tiab] OR \"TH9507\"[tiab] OR egrifta[tiab]", "count": 105, "note": "Tesamorelin (Egrifta), FDA-approved; for comparison.", "pmids": [ "42862021", "42538058", "42419889", "42395176", "42382101", "42160466", "42139091", "42123471", "42018810", "41966639", "41598480", "41545261", "41490200", "41476424", "41138283", "40510111", "40397552", "39813152", "39746672", "38905488", "38416754", "38197510", "37806509", "36845310", "36165079", "38716080", "35298973", "35137140", "34665524", "34588764", "34006921", "33852720", "33756511", "32971474", "32701508", "32270862", "31840988", "31611038", "31611037", "31237318", "30804324", "31644039", "29031905", "28832410", "28793863", "28617838", "28477736", "30920787", "30896908", "30896905", "27192539", "26879649", "26457580", "26382721", "25895899", "25358450", "25038357", "24178787", "24054930", "27121785", "23689947", "23657561", "23015655", "22926095", "22869065", "22748602", "22701839", "22495074", "22298602", "22096409", "22050344", "21695284", "21687371", "21668043", "21591600", "21531600", "21516030", "21283099", "21265979", "30764032", "21124215", "21115997", "20943777", "20872317", "20554713", "20216906", "20101189", "19243281", "18828236", "18724445", "18690162", "18069152", "18057338", "17575575", "17571443", "17214611", "17086939", "16395422", "16273137", "16179960", "16082422", "16052083", "15538546", "15319815", "15113616" ] }, { "key": "tesa_trial", "query": "(tesamorelin[tiab] OR \"TH9507\"[tiab] OR egrifta[tiab]) AND (clinical trial[pt] OR randomized controlled trial[pt])", "count": 24, "note": "Tesamorelin trials with Clinical Trial or RCT publication type.", "pmids": [ "39813152", "38905488", "33852720", "32701508", "32270862", "31611038", "31237318", "29031905", "28617838", "26457580", "25895899", "25358450", "25038357", "24178787", "23689947", "23015655", "22869065", "22495074", "21531600", "21516030", "20101189", "18690162", "18057338", "16052083" ] } ], "records": [ { "pmid": "9733495", "year": "1998", "title": "A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.", "journal": "J Med Chem", "publication_types": [ "Journal Article" ] }, { "pmid": "9733496", "year": "1998", "title": "Novel orally active growth hormone secretagogues.", "journal": "J Med Chem", "publication_types": [ "Journal Article" ] }, { "pmid": "9849822", "year": "1998", "title": "Ipamorelin, the first selective growth hormone secretagogue.", "journal": "Eur J Endocrinol", "publication_types": [ "Journal Article" ] }, { "pmid": "9879640", "year": "1998", "title": "Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.", "journal": "Xenobiotica", "publication_types": [ "Comparative Study", "Journal Article" ] }, { "pmid": "10373343", "year": "1999", "title": "Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.", "journal": "Growth Horm IGF Res", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "10427162", "year": "1999", "title": "Pharmacological characterisation of a new oral GH secretagogue, NN703.", "journal": "Eur J Endocrinol", "publication_types": [ "Journal Article" ] }, { "pmid": "10496658", "year": "1999", "title": "Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.", "journal": "Pharm Res", "publication_types": [ "Clinical Trial", "Journal Article", "Randomized Controlled Trial" ] }, { "pmid": "10629165", "year": "1999", "title": "Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats.", "journal": "Growth Horm IGF Res", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "10828840", "year": "2000", "title": "The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.", "journal": "J Endocrinol", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "11162489", "year": "2001", "title": "Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues.", "journal": "Biochem Biophys Res Commun", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "11322495", "year": "2001", "title": "Do growth hormone-releasing peptides act as ghrelin secretagogues?", "journal": "Endocrine", "publication_types": [ "Comparative Study", "Journal Article" ] }, { "pmid": "11459660", "year": "2001", "title": "Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.", "journal": "Bioorg Med Chem Lett", "publication_types": [ "Journal Article" ] }, { "pmid": "11735244", "year": "2001", "title": "The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats.", "journal": "Growth Horm IGF Res", "publication_types": [ "Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "12168778", "year": "2002", "title": "Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro.", "journal": "Histol Histopathol", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "12204475", "year": "2002", "title": "The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.", "journal": "Eur J Med Chem", "publication_types": [ "Journal Article" ] }, { "pmid": "14630569", "year": "2003", "title": "Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue.", "journal": "Exp Diabesity Res", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "15113616", "year": "2004", "title": "Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.", "journal": "Int J Pharm", "publication_types": [ "Journal Article" ] }, { "pmid": "15319815", "year": "2004", "title": "Gateways to clinical trials.", "journal": "Methods Find Exp Clin Pharmacol", "publication_types": [ "Bibliography", "Journal Article" ] }, { "pmid": "15538546", "year": "2004", "title": "Gateways to clinical trials.", "journal": "Methods Find Exp Clin Pharmacol", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "15556068", "year": "2004", "title": "Stimulation of growth hormone secretion from seabream pituitary cells in primary culture by growth hormone secretagogues is independent of growth hormone transcription.", "journal": "Comp Biochem Physiol C Toxicol Pharmacol", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "15665799", "year": "2004", "title": "Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats.", "journal": "Neuro Endocrinol Lett", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "15817669", "year": "2005", "title": "Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.", "journal": "Endocrinology", "publication_types": [ "Journal Article" ] }, { "pmid": "16052083", "year": "2005", "title": "A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation.", "journal": "AIDS", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "16082422", "year": "2005", "title": "Gateways to clinical trials.", "journal": "Methods Find Exp Clin Pharmacol", "publication_types": [ "Bibliography", "Journal Article" ] }, { "pmid": "16179960", "year": "2005", "title": "Gateways to clinical trials.", "journal": "Methods Find Exp Clin Pharmacol", "publication_types": [ "Bibliography", "Journal Article" ] }, { "pmid": "16273137", "year": "2005", "title": "Gateways to clinical trials.", "journal": "Methods Find Exp Clin Pharmacol", "publication_types": [ "Journal Article" ] }, { "pmid": "16395422", "year": "2005", "title": "Gateways to clinical trials.", "journal": "Methods Find Exp Clin Pharmacol", "publication_types": [ "Bibliography", "Journal Article" ] }, { "pmid": "16352683", "year": "2006", "title": "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "16648303", "year": "2006", "title": "Seabream ghrelin: cDNA cloning, genomic organization and promoter studies.", "journal": "J Endocrinol", "publication_types": [ "Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "16822960", "year": "2006", "title": "Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.", "journal": "Am J Physiol Endocrinol Metab", "publication_types": [ "Journal Article" ] }, { "pmid": "17018654", "year": "2006", "title": "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Clinical Trial", "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "17086939", "year": "2006", "title": "Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor.", "journal": "Curr Opin Investig Drugs", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "17214611", "year": "2007", "title": "Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.", "journal": "Basic Clin Pharmacol Toxicol", "publication_types": [ "Journal Article" ] }, { "pmid": "17571443", "year": "2007", "title": "Side effects and complications. Clinical trials of tesamorelin in Canada.", "journal": "TreatmentUpdate", "publication_types": [ "Newspaper Article", "Journal Article" ] }, { "pmid": "17575575", "year": "2007", "title": "Side effects and complications. Tesamorelin--results from Phase III.", "journal": "TreatmentUpdate", "publication_types": [ "Newspaper Article", "Journal Article" ] }, { "pmid": "18057338", "year": "2007", "title": "Metabolic effects of a growth hormone-releasing factor in patients with HIV.", "journal": "N Engl J Med", "publication_types": [ "Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "18069152", "year": "2007", "title": "TH9507: an experimental treatment for lipodystrophy.", "journal": "BETA", "publication_types": [ "Newspaper Article", "Journal Article" ] }, { "pmid": "18690162", "year": "2008", "title": "Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.", "journal": "AIDS", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "18724445", "year": "2008", "title": "Tesamorelin for fat accumulation. 52-week effects and safety of tesamorelin (growth hormone releasing factor) in HIV patients with fat accumulation.", "journal": "Posit Aware", "publication_types": [ "Newspaper Article", "Journal Article" ] }, { "pmid": "18828236", "year": "2008", "title": "The next generation of human growth hormone. How Serostim and tesamorelin measure up.", "journal": "Posit Aware", "publication_types": [ "Newspaper Article", "Journal Article" ] }, { "pmid": "19231263", "year": "2009", "title": "Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats.", "journal": "Growth Horm IGF Res", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "19243281", "year": "2009", "title": "Tesamorelin, a human growth hormone releasing factor analogue.", "journal": "Expert Opin Investig Drugs", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "19289567", "year": "2009", "title": "Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus.", "journal": "J Pharmacol Exp Ther", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "19332789", "year": "2009", "title": "Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth.", "journal": "Proc Natl Acad Sci U S A", "publication_types": [ "Journal Article", "Research Support, N.I.H., Intramural" ] }, { "pmid": "19386527", "year": "2009", "title": "Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.", "journal": "Growth Horm IGF Res", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "20101189", "year": "2010", "title": "Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.", "journal": "J Acquir Immune Defic Syndr", "publication_types": [ "Journal Article", "Randomized Controlled Trial" ] }, { "pmid": "20216906", "year": "2010", "title": "Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection.", "journal": "AIDS Rev", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "20554713", "year": "2010", "title": "Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "20872317", "year": "2010", "title": "Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy.", "journal": "Curr Opin Investig Drugs", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "21115997", "year": "2010", "title": "FDA approves tesamorelin for HIV-related lipodystrophy.", "journal": "Am J Health Syst Pharm", "publication_types": [ "News" ] }, { "pmid": "21204297", "year": "2010", "title": "Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article" ] }, { "pmid": "21591600", "year": "2010", "title": "Tesamorelin update.", "journal": "BETA", "publication_types": [ "Newspaper Article", "Journal Article" ] }, { "pmid": "20943777", "year": "2011", "title": "Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural" ] }, { "pmid": "21124215", "year": "2011", "title": "Pathogenesis and treatment of HIV lipohypertrophy.", "journal": "Curr Opin Infect Dis", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural", "Review" ] }, { "pmid": "21265979", "year": "2011", "title": "Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.", "journal": "HIV Med", "publication_types": [ "Journal Article", "Systematic Review" ] }, { "pmid": "21283099", "year": "2011", "title": "Tesamorelin.", "journal": "Nat Rev Drug Discov", "publication_types": [ "News" ] }, { "pmid": "21298258", "year": "2011", "title": "Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.", "journal": "Anal Bioanal Chem", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "21516030", "year": "2011", "title": "Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.", "journal": "AIDS", "publication_types": [ "Clinical Trial, Phase III", "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "21531600", "year": "2011", "title": "Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor.", "journal": "Growth Horm IGF Res", "publication_types": [ "Clinical Trial", "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "21668043", "year": "2011", "title": "Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.", "journal": "Drugs", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "21687371", "year": "2011", "title": "Tesamorelin: A hope for ART-induced lipodystrophy.", "journal": "J Pharm Bioallied Sci", "publication_types": [ "Journal Article" ] }, { "pmid": "21695284", "year": "2011", "title": "Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissue.", "journal": "Drugs Today (Barc)", "publication_types": [ "Journal Article" ] }, { "pmid": "22050344", "year": "2011", "title": "Spotlight on tesamorelin in HIV-associated lipodystrophy.", "journal": "BioDrugs", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "22096409", "year": "2011", "title": "Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy.", "journal": "HIV AIDS (Auckl)", "publication_types": [ "Journal Article" ] }, { "pmid": "30764032", "year": "2011", "title": "Tesamorelin for the treatment of excess abdominal fat in HIV-1-infected patients with lipodystrophy.", "journal": "Expert Rev Endocrinol Metab", "publication_types": [ "Journal Article" ] }, { "pmid": "21871962", "year": "2012", "title": "Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.", "journal": "Methods", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't", "Review" ] }, { "pmid": "22298602", "year": "2012", "title": "Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy.", "journal": "Ann Pharmacother", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "22495074", "year": "2012", "title": "Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.", "journal": "Clin Infect Dis", "publication_types": [ "Clinical Trial, Phase III", "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "22701839", "year": "2012", "title": "Pathogenesis and treatment of human immunodeficiency virus lipodystrophy.", "journal": "Indian J Endocrinol Metab", "publication_types": [ "Journal Article" ] }, { "pmid": "22748602", "year": "2012", "title": "How to diagnose a lipodystrophy syndrome.", "journal": "Ann Endocrinol (Paris)", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "22869065", "year": "2012", "title": "Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.", "journal": "Arch Neurol", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S." ] }, { "pmid": "22901302", "year": "2012", "title": "Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.", "journal": "J Chromatogr A", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "22926095", "year": "2012", "title": "Neuroendocrinology: Tesamorelin can improve cognitive function.", "journal": "Nat Rev Endocrinol", "publication_types": [ "Journal Article" ] }, { "pmid": "23015655", "year": "2012", "title": "Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural" ] }, { "pmid": "23101768", "year": "2012", "title": "Metabolism of growth hormone releasing peptides.", "journal": "Anal Chem", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "27186127", "year": "2012", "title": "Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus.", "journal": "J Exp Pharmacol", "publication_types": [ "Journal Article" ] }, { "pmid": "31644039", "year": "2012", "title": "Tesamorelin.", "journal": "", "publication_types": [ "Review" ] }, { "pmid": "23318763", "year": "2013", "title": "Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.", "journal": "Anal Bioanal Chem", "publication_types": [ "Evaluation Study", "Journal Article" ] }, { "pmid": "23657561", "year": "2013", "title": "Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.", "journal": "Rev Endocr Metab Disord", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "23689947", "year": "2013", "title": "Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.", "journal": "JAMA Neurol", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural" ] }, { "pmid": "24054930", "year": "2013", "title": "Growth hormone in the aging male.", "journal": "Best Pract Res Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S.", "Review" ] }, { "pmid": "27121785", "year": "2013", "title": "Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers.", "journal": "Clin Pharmacol Drug Dev", "publication_types": [ "Journal Article" ] }, { "pmid": "24178787", "year": "2014", "title": "The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "24574167", "year": "2014", "title": "A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Validation Study" ] }, { "pmid": "25038357", "year": "2014", "title": "Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.", "journal": "JAMA", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural" ] }, { "pmid": "25331030", "year": "2014", "title": "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.", "journal": "Int J Colorectal Dis", "publication_types": [ "Clinical Trial, Phase II", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "25382550", "year": "2014", "title": "Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.", "journal": "Expert Rev Proteomics", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "25358450", "year": "2015", "title": "Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.", "journal": "Clin Pharmacokinet", "publication_types": [ "Clinical Trial, Phase I", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "25869809", "year": "2015", "title": "Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't", "Validation Study" ] }, { "pmid": "25895899", "year": "2015", "title": "Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects.", "journal": "J Pharmacokinet Pharmacodyn", "publication_types": [ "Clinical Trial, Phase I", "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "26382721", "year": "2015", "title": "Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't", "Validation Study" ] }, { "pmid": "26457580", "year": "2015", "title": "Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat.", "journal": "PLoS One", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "27722075", "year": "2015", "title": "Experimental Sensing and Density Functional Theory Study of H2S and SOF2 Adsorption on Au-Modified Graphene.", "journal": "Adv Sci (Weinh)", "publication_types": [ "Journal Article" ] }, { "pmid": "26472487", "year": "2016", "title": "Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Validation Study" ] }, { "pmid": "26578461", "year": "2016", "title": "Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.", "journal": "J Sep Sci", "publication_types": [ "Evaluation Study", "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "26771670", "year": "2016", "title": "Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.", "journal": "Subst Use Misuse", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "26879649", "year": "2016", "title": "Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.", "journal": "Anal Bioanal Chem", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't", "Validation Study" ] }, { "pmid": "27192539", "year": "2016", "title": "Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury.", "journal": "Expert Opin Ther Targets", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "27537844", "year": "2016", "title": "Functional Properties of Glutinous Rice Flour by Dry-Heat Treatment.", "journal": "PLoS One", "publication_types": [ "Journal Article" ] }, { "pmid": "27710891", "year": "2016", "title": "The study of doping market: How to produce intelligence from Internet forums.", "journal": "Forensic Sci Int", "publication_types": [ "Journal Article" ] }, { "pmid": "30896905", "year": "2016", "title": "", "journal": "", "publication_types": [ "Review" ] }, { "pmid": "30896908", "year": "2016", "title": "", "journal": "", "publication_types": [ "Review" ] }, { "pmid": "30920787", "year": "2016", "title": "", "journal": "", "publication_types": [ "Review" ] }, { "pmid": "26811125", "year": "2017", "title": "Structure-activity relationship for peptídic growth hormone secretagogues.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article" ] }, { "pmid": "27497113", "year": "2017", "title": "Doping control container for urine stabilization: a pilot study.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article" ] }, { "pmid": "28477736", "year": "2017", "title": "Growth hormone deficiency and human immunodeficiency virus.", "journal": "Best Pract Res Clin Endocrinol Metab", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "28617838", "year": "2017", "title": "Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.", "journal": "PLoS One", "publication_types": [ "Journal Article", "Multicenter Study", "Randomized Controlled Trial" ] }, { "pmid": "28793863", "year": "2017", "title": "Cardiovascular risk and dyslipidemia among persons living with HIV: a review.", "journal": "BMC Infect Dis", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "28832410", "year": "2017", "title": "Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.", "journal": "AIDS", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural" ] }, { "pmid": "29031905", "year": "2017", "title": "Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.", "journal": "Growth Horm IGF Res", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural" ] }, { "pmid": "29851844", "year": "2018", "title": "Effect produced on ground reaction forces by a prefabricated, weight-bearing and non-weight-bearing foot orthosis in the treatment of pronated foot: Pilot study.", "journal": "Medicine (Baltimore)", "publication_types": [ "Clinical Trial", "Journal Article" ] }, { "pmid": "29864719", "year": "2018", "title": "Analysis of new growth promoting black market products.", "journal": "Growth Horm IGF Res", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "30168238", "year": "2018", "title": "A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.", "journal": "J Pept Sci", "publication_types": [ "Journal Article" ] }, { "pmid": "30282322", "year": "2018", "title": "Peptidomimetic growth hormone secretagogue derivatives for positron emission tomography imaging of the ghrelin receptor.", "journal": "Eur J Med Chem", "publication_types": [ "Journal Article" ] }, { "pmid": "30136411", "year": "2019", "title": "Glycine-modified growth hormone secretagogues identified in seized doping material.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article" ] }, { "pmid": "30489688", "year": "2019", "title": "An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Validation Study" ] }, { "pmid": "30804324", "year": "2019", "title": "Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV.", "journal": "Nutr Diabetes", "publication_types": [ "Comparative Study", "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "30938069", "year": "2019", "title": "A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Validation Study" ] }, { "pmid": "31237318", "year": "2019", "title": "The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV.", "journal": "J Frailty Aging", "publication_types": [ "Journal Article", "Randomized Controlled Trial" ] }, { "pmid": "31611037", "year": "2019", "title": "Tesamorelin, liver fat, and NAFLD in the setting of HIV.", "journal": "Lancet HIV", "publication_types": [ "Journal Article", "Comment" ] }, { "pmid": "31611038", "year": "2019", "title": "Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.", "journal": "Lancet HIV", "publication_types": [ "Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural" ] }, { "pmid": "31840988", "year": "2020", "title": "Peptide Ligation at High Dilution via Reductive Diselenide-Selenoester Ligation.", "journal": "J Am Chem Soc", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "32257855", "year": "2020", "title": "Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.", "journal": "Transl Androl Urol", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "32701508", "year": "2020", "title": "Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD.", "journal": "JCI Insight", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "32801950", "year": "2020", "title": "Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.", "journal": "J Exp Pharmacol", "publication_types": [ "Journal Article" ] }, { "pmid": "32971474", "year": "2020", "title": "Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.", "journal": "J Chromatogr A", "publication_types": [ "Journal Article" ] }, { "pmid": "32270862", "year": "2021", "title": "Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease.", "journal": "Clin Infect Dis", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural" ] }, { "pmid": "33756511", "year": "2021", "title": "Tesamorelin improves fat quality independent of changes in fat quantity.", "journal": "AIDS", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural" ] }, { "pmid": "33852720", "year": "2021", "title": "Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.", "journal": "Clin Infect Dis", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, N.I.H., Extramural", "Research Support, N.I.H., Intramural" ] }, { "pmid": "34006921", "year": "2021", "title": "Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.", "journal": "Sci Rep", "publication_types": [ "Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "34588764", "year": "2021", "title": "Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease.", "journal": "Drug Des Devel Ther", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "34665524", "year": "2021", "title": "Advances in the detection of growth hormone releasing hormone synthetic analogs.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article", "Validation Study" ] }, { "pmid": "34736642", "year": "2022", "title": "Early detection of cannabinoids in biological samples based on their affinity interaction with the growth hormone secretagogue receptor.", "journal": "Talanta", "publication_types": [ "Journal Article" ] }, { "pmid": "35137140", "year": "2022", "title": "Approach to the Patient With Lipodystrophy.", "journal": "J Clin Endocrinol Metab", "publication_types": [ "Case Reports", "Journal Article", "Research Support, N.I.H., Extramural" ] }, { "pmid": "35298973", "year": "2022", "title": "An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.", "journal": "J Pharm Biomed Anal", "publication_types": [ "Journal Article" ] }, { "pmid": "36165079", "year": "2022", "title": "Causes and outcomes of hepatic fibrosis in persons living with HIV.", "journal": "Curr Opin HIV AIDS", "publication_types": [ "Journal Article", "Review", "Research Support, N.I.H., Extramural" ] }, { "pmid": "38716080", "year": "2022", "title": "Probing for peptidic drugs (2-10 kDa) in doping control blood samples.", "journal": "Anal Sci Adv", "publication_types": [ "Journal Article" ] }, { "pmid": "36845310", "year": "2023", "title": "Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial.", "journal": "J Clin Transl Sci", "publication_types": [ "Journal Article" ] }, { "pmid": "37806509", "year": "2023", "title": "Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.", "journal": "Anal Biochem", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "38197510", "year": "2024", "title": "Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.", "journal": "J Mass Spectrom", "publication_types": [ "Journal Article" ] }, { "pmid": "38416754", "year": "2024", "title": "Dietary regimens appear to possess significant effects on the development of combined antiretroviral therapy (cART)-associated metabolic syndrome.", "journal": "PLoS One", "publication_types": [ "Journal Article" ] }, { "pmid": "38905488", "year": "2024", "title": "Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.", "journal": "AIDS", "publication_types": [ "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural" ] }, { "pmid": "38996639", "year": "2024", "title": "Effects of protein-glutaminase on the properties of glutinous rice flour, paste, and gel food: Based on the interactions between the deamidated protein and starch.", "journal": "Food Chem", "publication_types": [ "Journal Article" ] }, { "pmid": "38996787", "year": "2024", "title": "The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.", "journal": "Anim Reprod Sci", "publication_types": [ "Journal Article" ] }, { "pmid": "39043357", "year": "2024", "title": "The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.", "journal": "Physiol Behav", "publication_types": [ "Journal Article", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "39746672", "year": "2024", "title": "CROI 2024: Neuropsychiatric Complications in People With HIV.", "journal": "Top Antivir Med", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "39813152", "year": "2025", "title": "Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity.", "journal": "J Infect Dis", "publication_types": [ "Clinical Trial, Phase II", "Journal Article", "Multicenter Study", "Randomized Controlled Trial" ] }, { "pmid": "40397552", "year": "2025", "title": "Metabolic dysfunction-associated steatotic liver disease in people with HIV.", "journal": "Curr Opin HIV AIDS", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "40510111", "year": "2025", "title": "Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study.", "journal": "Cureus", "publication_types": [ "Journal Article" ] }, { "pmid": "41138283", "year": "2026", "title": "Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.", "journal": "J Pharm Biomed Anal", "publication_types": [ "Journal Article" ] }, { "pmid": "41476424", "year": "2026", "title": "Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.", "journal": "Am J Sports Med", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "41490200", "year": "2026", "title": "Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.", "journal": "J Am Acad Orthop Surg Glob Res Rev", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "41545261", "year": "2026", "title": "Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.", "journal": "Obes Res Clin Pract", "publication_types": [ "Meta-Analysis", "Journal Article", "Systematic Review" ] }, { "pmid": "41598480", "year": "2026", "title": "Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss.", "journal": "J Clin Med", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "41880199", "year": "2026", "title": "A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.", "journal": "J Sports Med Phys Fitness", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "41966639", "year": "2026", "title": "Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.", "journal": "Sports Med", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "42018810", "year": "2026", "title": "Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model.", "journal": "Braz J Med Biol Res", "publication_types": [ "Journal Article" ] }, { "pmid": "42021992", "year": "2026", "title": "Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.", "journal": "Front Aging", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "42123471", "year": "2026", "title": "Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.", "journal": "Int J Mol Sci", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "42139091", "year": "2026", "title": "Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists.", "journal": "Clin Infect Dis", "publication_types": [ "Journal Article", "Case Reports", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "42160466", "year": "2026", "title": "Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.", "journal": "JBJS Rev", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "42382101", "year": "2026", "title": "The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.", "journal": "eNeurologicalSci", "publication_types": [ "Journal Article" ] }, { "pmid": "42395176", "year": "2026", "title": "The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.", "journal": "Front Endocrinol (Lausanne)", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "42419889", "year": "2026", "title": "Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol.", "journal": "BMJ Open", "publication_types": [ "Journal Article", "Clinical Trial Protocol" ] }, { "pmid": "42538058", "year": "2026", "title": "Efficacy and Safety of Tesamorelin in People Living With HIV (PLWH) With Lipodystrophy: A Systematic Review and Meta-Analysis.", "journal": "J Int Assoc Provid AIDS Care", "publication_types": [ "Journal Article", "Systematic Review", "Meta-Analysis" ] }, { "pmid": "42578445", "year": "2026", "title": "Peptide Supplements and Their Therapeutic Applications in Sports Medicine.", "journal": "Am J Sports Med", "publication_types": [ "Journal Article" ] }, { "pmid": "42862021", "year": "2026", "title": "Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.", "journal": "Sex Med Rev", "publication_types": [ "Journal Article", "Review" ] }, { "pmid": "42876013", "year": "2026", "title": "Detection of CJC-1295 in Equine Plasma by ELISA.", "journal": "Drug Test Anal", "publication_types": [ "Journal Article" ] } ] }